Advanced Search

 

Study ID Status Title Patient Level Data
206827 Recruiting A randomized, evaluator-blind, single-center and two-arm clinical study designed to evaluate the local tolerance and cosmetic efficacy of a topical skin care formulation in healthy female subjects with mild to advanced photo-damaged facial skin who have undergone a 70% Glycolic Acid facial peel procedure.
206886 Completed Dose Response of Three Experimental Dentifrices in Plaque Removal in a Single Brushing Model
206901 Not yet recruiting A randomized, open-label, cross-over, placebo inhaler study to evaluate the correct use of ELLIPTA™ dry powder inhaler (DPI) compared to DISKUS™ DPI used in combination with HandiHaler DPI in participants with Chronic Obstructive Pulmonary Disease (COPD)
206938 Not yet recruiting Meta Analysis of Dual Bronchodilators Impact of Lung Function Benefit vs. Spiriva
207014 Not yet recruiting A Clinical Study Investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population.
207136 Recruiting Patient Characteristics and Treatment Modalities in COPD Patients Assessed by GOLD2016 : a Cross-Sectional Study in China
207192 Recruiting Impact of a Nutritional supplement on Bone turnover markers in Indian healthy premenopausal women (25-45 yrs; inclusive) after 6 months of intervention: a randomised double blind controlled trial
207196 Completed A randomised, parallel-group, evaluator-blind, no-treatment and positive controlled, single-site, proof of concept clinical study to evaluate the cosmetic benefit provided by 8 weeks of twice-daily topical application of a developmental moisturising cream with niacinamide in healthy subjects with sensitive, oily, blemish-prone skin
207211 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
207212 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
207213 Completed A randomized, evaluator-blind, single-center and two arm clinical study designed to evaluate the local tolerance and cosmetic efficacy of a topical skin care formulation in healthy female subjects with mild to advanced photo-damaged facial skin who have undergone a 70% Glycolic Acid facial peel procedure
207235 Completed A Human Subject 24 Hour Patch Test to Assess the Irritation Potential of Four Skin Serum Products
207236 Recruiting A Phase III, 52-week, Open-label Study to Evaluate Long-term Safety of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Patients with Asthma
207238 Completed A proof-of-principle clinical study investigating the efficacy of a dissolvable strip in providing rapid relief from dentinal hypersensitivity.
207255 Not yet recruiting Indirect treatment comparison of IV formulation and SC formulation of belimumab for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
207264 Not yet recruiting Retrospective study of asthma patients prescribed with ICS/LABA maintenance medications using a Japan Medical Data Center (JMDC) Claim database in Japan
207266082 Completed A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Safety and Efficacy of SB 207266 in Patients with Symptomatic Persistent Atrial Fibrillation (AF)
207267 Not yet recruiting Assessment of Patients Treated with Albiglutide – Phase 2
207323 Active, not recruiting Burden of illness among patients with eosinophilic severe COPD
207348 Active, not recruiting Meta-analysis of studies MEA112997 and MEA115588 of mepolizumab (SB240563) in severe asthma – additional subgroup analyses of exacerbations and investigation of relationship of FEV1 to exacerbations (eTrack Study Identifier 207348)
207351 Active, not recruiting Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Albiglutide during Pregnancy
207387 Completed PGx7665: Exploratory Pharmacogenetic analysis of response to GSK2269557, a PI3 kinase delta inhibitor in patients from study 116678 with COPD
207388 Not yet recruiting PGx7666: Exploratory pharmacogenetic investigation of efficacy response to advair in COPD studies 116135, 116136, 111117, 114930, 114951, 116134, 112352, 113107, 113109, 116974
207389 Recruiting PGx7667 (207389) Exploratory Pharmacogenetic Investigation of Efficacy Response to mepolizumab in Eosinophilic Granulomatosis Polyangiitis (Churg-Strauss Syndrome) study 115921
207390 Not yet recruiting PGx7669: an exploratory pharmacogenetic efficacy investigation of steroid reduction in subjects with severe asthma treated with mepolizumab in 115575 and 115661

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.